At last years BioPharma India Convention Anil Pareek, President of Medical Affairs and Clinical Research, Ipca Laboratories Limited delivered the presentation: Innovation Challenge, the role of Indian Pharma
Points covered in this presentation include:
• New product pipeline is drying: just 6% of sales in 2011 were of medicines launched in the past 5 yrs (down from 8% in 2008)
• Ageing Portfolios
• Medicines failing in late development on rise
• Number of drugs failing at Phase III has doubled in the period 2007- 2009 Vs 2004-2006................Source Thomson Reuters
• NMEs launched in 2010 are just half of those hitting the market in 90’s
• Generics on rise and blockbuster era on decline